Aims: The aim of the study was to evaluate some clinicopathologic character
istics and the outcome of patients with ovarian germ cell cancer (OGCC) tre
ated with cisplatin-based chemotherapy.
Methods: It was a clinical retrospective study. The clinical charts of 31 p
atients with OGCC assisted at the Department of Obstetrics and Gynecology o
f the State University of Campinas, Brazil, from January 1986 to June 1997
were reviewed.
Results: Ten patients had dysgerminoma and 21 patients nondysgerminomatous
tumors. Women with dysgerminoma and nondysgerminomatous tumors did not pres
ent differences regarding surgical staging, age, ascites or residual tumor
after the Initial surgery. Frozen section, performed in 16 patients, showed
some discrepancy with paraffin histology diagnosis in 8 patients. Platinum
-based chemotherapy was used in 5/10 patients with dysgerminoma and in 17/2
1 patients with nondysgerminomatous tumors, with a 5-year survival of 100%
for the dysgerminoma and 53% for the nondysgerminomatous group.
Conclusions: women with dysgerminoma and nondysgerminomatous tumors did not
present differences regarding clinicopathologic characteristics. The progn
osis for patients with dysgerminoma was better than for those with nondysge
rminomatous tumors. Frozen section had a high error rate in diagnosing OGCC
intraoperatively.